Albumin Microspheres II: Applications in Drug Delivery

References

• Anderson J. M., Niven H., Pelagalli J., Olanoff L. S., Jones R. D. The role of the fibrous capsule in the function of implanted drug-polymer sustained release system. Journal of Biomedical Material Research 1981; 15: 889–902
   PubMed Web of Science ®Google Scholar
• Bernard N. G., Shaw S. M., Kessler W. V., Landolt R. R., Peck G. E., Dockerty G. H. Distribution and degradation of iodine-125 albumin microspheres and technetium-99m sulphur colloid. Journal of Pharmaceutical Sciences 1980; 15: 30–34
   Google Scholar
• Bouveng R., Schildt B., Sjoqvjst J. Estimation of RES phagocytosis and catabolism in man by the use of 125I-labeled microaggregates of human serum albumin. Journal of Reticuloendothelial Society 1975; 18: 151–159
   PubMedGoogle Scholar
• Burger J. J., McVie J. G. Microspheres for tumor targeting of cytotoxic drugs. Pharmaceutish Weekblad 1985; 7: 27
   Google Scholar
• Burger J. J., Tomlinson E., Mulder E. M. A., McVie J. G. Albumin microspheres for intra-arterial tumour targeting I. Pharmaceutical aspects. International Journal of Pharmaceutics 1985a; 23: 333–344
   Web of Science ®Google Scholar
• Burger J. J., Tomlinson E., McVie J. G. Microparticles intended for microvascular blockage. Drug incorporation and release. Drug Targeting, P. Buri, A. Gumma. Elsevier, Amsterdam 1985b; 81–94
   Google Scholar
• Burgess D. J., Davis S. S. Prednisolone release from albumin microspheres: in vitro, and in vivo, studies by intra-articular injection into rabbits. Journal of Pharmacy and Pharmacology 1986; 38: 23P
   Google Scholar
• Davis M. A., Taube R. A. Pulmonary perfusion imaging: acute toxicity and safety factors as a function of particle size. Journal of Nuclear Medicine 1978; 19: 1209–1213
   Web of Science ®Google Scholar
• Davis S. S., Hunneyball I. M., Illum L., Ratcliffe J. H., Smith A., Wilson C. G. Recent advances in the use of microspheres for targeted therapy. Drugs under Experimental and Clinical Research 1985; 11: 633–640
   PubMedGoogle Scholar
• DsLuca P., Kanke M., Bivins B., Slack J., Simmons G., Yokel R., Schroeder H., Sniecinski I. The fate and effects of Ce141-labelled microspheres following IV or IA administration in beagle dogs. Presented at the Second Congress International de Technologie Pharmaceutique, Paris, 1980
   Google Scholar
• Ford L., Shroff A., Benson W., Atkins H., Rhodes B. A. SNM drug problem reporting system. Journal of Nuclear Medicine 1978; 19: 116–117
   PubMedGoogle Scholar
• Fujimoto S., Endoh F., Kitsukawa Y., Okui K., Morimoto Y., Sugibayashi K., Miyakawa A., Suzuki H. in vitro, and in vivo, release of an antitumour drug from albumin microspheres. Experimentia 1983; 39: 913–916, Continued
   PubMedGoogle Scholar
• Fujimoto S., Endoh F., Miyazaki M., Shrestha R. D., Okui K., Morimoto Y. Intra-arterial administration of heated albumin microspheres containing mitomycin C to rabbits with VX-2 tumor. Japanese Journal of Surgery 1984; 14: 252–257
   PubMedGoogle Scholar
• Fujimoto S., Miyazaki M., Endoh F., Takahashi O., Okui K., Sugibayashi K., Morimoto Y. Mitomycin C carrying microspheres as a novel method of drug delivery. Cancer Drug Delivery 1985a; 2: 173–181
   PubMedGoogle Scholar
• Fujimoto S., Miyazaki M., Endoh F., Takahashi O., Okui K., Morimoto Y. Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer with particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. Cancer 1985b; 56: 2404–2410
   PubMed Web of Science ®Google Scholar
• Fujimoto S., Miyazaki M., Endoh F., Takahashi O., Shrestha R. D., Okui K., Morimoto Y., Terao K. Effect of intra-arterially infused biodegradable microspheres containing mitomycin C. Cancer 1985c; 55: 522–526
   PubMedGoogle Scholar
• Gates G. F., Goris M. L. Stability of radiopharmaceuticals for determining right-to-left shunting. Journal of Nuclear Medicine 1977; 18: 255–257
   PubMedGoogle Scholar
• Goosen M. F. A., Leung Y. F., Chou S., Sun A. M. Insulin albumin microbeads: an implantable biodegradable system. Biomaterials Medical Devices and Artificial Organs 1982; 10: 205–218
   PubMed Web of Science ®Google Scholar
• Goosen M. F. A., Leung Y. F., O'Shea G. M., Chou S., Sun A. M. Slow release of insulin from a biodegradable matrix implanted in diabetic rats. Diabetes 1983; 32: 478–481
   PubMed Web of Science ®Google Scholar
• Grislain L., Couvreur P., Lenaehts V., Roland M., Dephez-Decampeneehs D., Speiser P. Pharmacokinetics and distribution of a biodegradable drug carrier. International Journal of Pharmaceutics 1983; 15: 335–345
   Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Lam F. C., Perrier D. G. Albumin microspheres III: Synthesis and characterization of microspheres containing adriamycin and magnetite. International Journal of Pharmaceutics 1988; 43: 167–177
   Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Perrier D. G. Albumin microspheres I: Release characteristics of adriamycin. International Journal of Pharmaceutics 1986; 33: 137–146
   Web of Science ®Google Scholar
• Hunneyball I. M. Intra-articular administration of drugs. Pharmacy International 1986; 7: 118–122
   Google Scholar
• Kanke M., Simmons G. H., Weiss D. L., Bivins B. A., DeLuca P. P. Clearance of 141Ce-labelled microspheres in specific organs following intravenous and intraarterial administration in beagle dogs. Journal of Pharmaceutical Sciences 1980; 69: 755–762
   PubMed Web of Science ®Google Scholar
• Illum L., Davis S. S. The targeting of drugs parenterally by use of microspheres. Journal of Parenteral Science and Technology 1982; 36: 242–248
   PubMedGoogle Scholar
• Lee T. K., Sokoloski T. D., Royer G. P. Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science 1981; 213: 233–235
   PubMed Web of Science ®Google Scholar
• Leucuta S. E., Risca R., Daicoviviu D., Porutiu D. Albumin microspheres as a drug delivery system for epirubicin: pharmaceutical, pharmacokinetic and biological aspects. International Journal of Pharmaceutics 1988; 41: 213–217
   Web of Science ®Google Scholar
• Littenberg R. L. Anaphylactoid reaction to human albumin microspheres. Journal of Nuclear Medicine 1975; 16: 236–237
   PubMed Web of Science ®Google Scholar
• McArdle C. S., Lewi H., Willmott N. Adriamycin-loaded albumin microspheres: a new method of delivering cytotoxic chemotherapy. Presented at IIIrd World Conference on Clinical Pharmacology and Experimental Therapeutics, Stockholm, 1986
   Google Scholar
• Morimoto Y., Fujimoto S. Albumin microspheres as drug carriers. CRC Critical Reviews in Therapeutic Drug Carrier Systems 1985; 2: 19–63
   PubMedGoogle Scholar
• Morimoto Y., Akimoto M., Sugibayashi K., Nadai T., Kato Y. Drug carrier property of albumin microspheres in chemotherapy. IV. Antitumour effect of single shot or multiple shot administration of microspheres entrapped 5-fluorouracil on Ehrlich ascites or solid tumour in mice. Chemical and Pharmaceutical Bulletin 1980; 28: 3087–3092
   PubMed Web of Science ®Google Scholar
• Morimoto Y., Sugibayashi K., Kato Y. Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumour effect of microsphere entrapped adriamycin on liver metastasis of AH 7974 cells in rat. Chemical and Pharmaceutical Bulletin 1981; 29: 1433–1438
   PubMed Web of Science ®Google Scholar
• Palmer D. R., Rifkind D., Brown D. W. 131I-labelled colloidal human serum albumin in the study of reticuloendothelial system function. II. Phagocytosis and catabolism of test colloid in normal subjects. Journal of Infectious Diseases 1971; 123: 457–460
   PubMedGoogle Scholar
• Przyborowski M., Lachnik E., Wiza J., Licinska I. Preparation of HSA microspheres in a one step thermal denaturation of protein aerosol carried in gas medium. European Journal of Nuclear Medicine 1982; 7: 71–72
   PubMedGoogle Scholar
• Pujara S. S., Russell C. D. Evaluation of peritoneo-venous shunt. Journal of Nuclear Medicine 1979; 20: 72–73
   PubMedGoogle Scholar
• Ratcliffe J. H., Hunneyball I. M., Smith A., Wilson C. G., Davis S. S. Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs. Journal of Pharmacy and Pharmacology 1984a; 36: 431–436
   PubMed Web of Science ®Google Scholar
• Ratcliffe J. H., Hunneyball I. M., Wilson C. G., Smith A., Davis S. S. The potential of albumin microspheres as an intra-articular drug delivery system. British Journal of Rheumatology 1984b; 23: 118
   Google Scholar
• Ratcliffe J. H., Hunneyball I. M., Wilson C. G., Smith A., Davis S. S. Microsphere systems for intraarticular drug administration. Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, New York 1984c; 345
   Google Scholar
• Ratcliffe J. H., Hunneyball I. M., Wilson C. G., Smith A., Davis S. S. Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits. Journal of Pharmacy and Pharmacology 1987; 39: 290–295
   PubMed Web of Science ®Google Scholar
• Rhodes B. A., Zolle I., Buchanan J. W., Wagner H. N. Radioactive albumin microspheres for studies of the pulmonary circulation. Radiology 1969; 92: 1453–1460
   PubMed Web of Science ®Google Scholar
• Rhodes B. A., Zolle I., Wagner H. N. Properties and uses of radioactive albumin microspheres. Clinical Research 1968; 16: 245
   Google Scholar
• Reske S. N., Vyska K., Feinendegen L. E. Kinetics of phagocytosis and proteolytic metabolism in liver macrophages in normal persons and tumour patients. Journal of Nuclear Medicine 1979; 20: 606
   Web of Science ®Google Scholar
• Reske S. N., Vyska K., Feinendegen L. E. In vivo, assessment of phagocytic properties of kupffer cells. Journal of Nuclear Medicine 1981; 22: 405–410
   PubMed Web of Science ®Google Scholar
• Royer G. P., Lee T. K., Sokoloski T. D. Entrapment of bioactive compounds within albumin beads. Journal of Parenteral Science & Technology 1983; 37: 34–37
   PubMedGoogle Scholar
• Samy T. S. A., Wellham L. L., Yen R. C. K., Kim S., Krishan A. Antitumor activity of doxorubicin entrapped in albumin microspheres. Proceedings of the American Association of Cancer Research 1986; 27: 404
   Google Scholar
• Scheffel U., Rhodes B. A., Natarajan T. K., Wagner M. N. Albumin microspheres for study of the reticuloendothelial system. Journal of Nuclear Medicine 1972; 13: 498–503
   PubMed Web of Science ®Google Scholar
• Slack J. D., Kanke M., Simmons G. H., DeLuca P. P. Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration. Journal of Pharmaceutical Sciences 1981; 70: 660–664
   PubMed Web of Science ®Google Scholar
• Sokoloski T. D., Royer G. P. Drug entrapment within native albumin beads. Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, Amsterdam 1984; 295–308
   Google Scholar
• Sugibayashi K., Akimoto M., Morimoto Y., Nadai T., Kato Y. Drugcarrier property of albumin microspheres in chemotherapy. III. Effect of microsphere-entrapped 5-fluorouracil on Ehrlich ascites carcinoma in mice. Journal of Pharmacobio-Dynamics 1979b; 2: 350–355
   Google Scholar
• Sugibayahshi K., Morimoto Y., Nadai T., Kato Y. Drug carrier property of albumin microspheres in chemotherapy. 1. Tissue distribution of microsphere entrapped 5-fluorouracil in mice. Chemical and Pharmaceutical Bulletin 1977; 25: 3433–3434
   PubMedGoogle Scholar
• Sugibayashi K., Morimoto Y., Nadai T., Kato Y., Hasegawaw A., Arita T. Drug carrier property of albumin microspheres in chemotherapy: 2. Preparation and tissue distribution in mice of microsphere entrapped 5-fluorouracil. Chemical and Pharmaceutical Bulletin 1979a; 27: 204–209
   PubMed Web of Science ®Google Scholar
• Taplin G. V., Dore E. K., Johnson D. E. Hepatic blood flow and reticuloendothelial system studies with radiocolloids. Clinical Dynamic Studies with Radioisotopes, R. M. Kniseley, W. N. Tauxe. Symposium Series 3, USAEC, TID, Oak Ridge 1964b; 285–317
   Google Scholar
• Taplin G. V., Johnson D. E., Dore E. K., Kaplan H. S. Suspensions of radioalbumin aggregates for photoscanning of the liver, spleen, lung and other organs. Journal of Nuclear Medicine 1964a; 5: 259–275
   PubMed Web of Science ®Google Scholar
• Wagner H. N., Jr, Rhodes B. A., Sasaki Y., Ryan J. P. Studies of the circulation with radioactive microspheres. Investigative Radiology 1969; 4: 374–386
   PubMed Web of Science ®Google Scholar
• Willmott N., Cummings J. Increases anti-tumor effect of adriamycin-loaded albumin microspheres in associated with anaerobic bioreduction of drug in tumor tissue. Biochemical Pharmacology 1987; 36: 521–526
   PubMed Web of Science ®Google Scholar
• Willmott N., Cummings J., Stuart J. F. B., Florence A. T. Adriamycinloaded albumin microspheres: lung entrapment and fate in the rat. Biopharmaceutics and Drug Disposition 1985; 6: 91–104
   PubMed Web of Science ®Google Scholar
• Willmott N., Kamel H. M. H., Cummings J., Stuart J. F. B., Florence A. T. Adriamycin-loaded albumin microspheres: Lung entrapment and fate in the rat. Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, New York 1984; 205–216
   Google Scholar
• Zolle I., Rhodes B. A., Wagner H. N., Jr. Preparation of metabolized radioactive human serum albumin microspheres for studies of the circulation. International Journal of Applied Radiation and Isotopes 1970a; 21: 155–167
   PubMedGoogle Scholar